These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8809164)

  • 41. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
    J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-aryl-substituted 2,5-dimethoxyphenethylamines: synthesis and serotonin 5-HT(2A) receptor affinities.
    Trachsel D; Nichols DE; Kidd S; Hadorn M; Baumberger F
    Chem Biodivers; 2009 May; 6(5):692-704. PubMed ID: 19479848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. cDNA cloning and characterization of guinea-pig leukotriene B4 receptor.
    Masuda K; Yokomizo T; Izumi T; Shimizu T
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):79-85. PubMed ID: 10432303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
    Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
    J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor.
    Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Martini C; Giannaccini G; Lucacchini A
    J Med Chem; 1996 Dec; 39(26):5083-91. PubMed ID: 8978839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists.
    Zwaagstra ME; Timmerman H; Tamura M; Tohma T; Wada Y; Onogi K; Zhang MQ
    J Med Chem; 1997 Mar; 40(7):1075-89. PubMed ID: 9089329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.
    Herron DK; Goodson T; Bollinger NG; Swanson-Bean D; Wright IG; Staten GS; Thompson AR; Froelich LL; Jackson WT
    J Med Chem; 1992 May; 35(10):1818-28. PubMed ID: 1316967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine receptor ligands. Part VII [1]: novel 3-substituted 5-phenyl-1, 2, 3, 4, 5, 6-hexahydro-azepino-[4, 5-b]indoles as ligands for the dopamine receptors.
    Decker M; Lehmann J
    Arch Pharm (Weinheim); 2003 Oct; 336(10):466-76. PubMed ID: 14582123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Essential fatty acids are antagonists of the leukotriene B4 receptor.
    Yagaloff KA; Franco L; Simko B; Burghardt B
    Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):293-7. PubMed ID: 7630916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and cytotoxic evaluation of new (4,5,6,7-tetrahydro-indol-1-yl)-3-R-propionic acids and propionic acid ethyl esters generated by molecular mimicry.
    Martínez R; Clara-Sosa A; Ramírez Apan MT
    Bioorg Med Chem; 2007 Jun; 15(11):3912-8. PubMed ID: 17395468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.
    Reiter LA; Koch K; Piscopio AD; Showell HJ; Alpert R; Biggers MS; Chambers RJ; Conklyn MJ; Cooper K; Cortina SR; Dibrino JN; Dominy BW; Farrell CA; Hingorani GP; Martinelli GJ; Ramchandani M; Wright KF
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1781-6. PubMed ID: 9873433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.
    Zwaagstra ME; Timmerman H; van de Stolpe AC; de Kanter FJ; Tamura M; Wada Y; Zhang MQ
    J Med Chem; 1998 Apr; 41(9):1428-38. PubMed ID: 9554876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
    Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
    Nakayama Y; Senokuchi K; Sakaki K; Kato M; Maruyama T; Miyazaki T; Ito H; Nakai H; Kawamura M
    Bioorg Med Chem; 1997 May; 5(5):971-85. PubMed ID: 9208106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of seleno-organic compounds on leukotriene B4 biosynthesis].
    Liu DP; Cheng GF; Bai JY; Guo ZR; Zhu XY
    Yao Xue Xue Bao; 1993; 28(6):472-6. PubMed ID: 8249607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists.
    Poudrel JM; Hullot P; Vidal JP; Girard JP; Rossi JC; Muller A; Bonne C; Bezuglov V; Serkov I; Renard P; Pfeiffer B
    J Med Chem; 1999 Dec; 42(26):5289-310. PubMed ID: 10639274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
    Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
    J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.